STOCK TITAN

Curaleaf's Select Brand Diversifies Edible Offerings with New Select Snooze Bites

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Curaleaf, a prominent cannabis provider, has launched Select Snooze Bites, combining THC and CBN in a 1:1 ratio for effective nighttime relief. This innovative product promises rapid absorption, with effects felt within 15-30 minutes. The growing demand for CBN products has reportedly generated $43 million in sales in key states. Select Snooze Bites will initially be available in Arizona and Nevada before expanding to California, Colorado, and others. Curaleaf operates 111 dispensaries across 23 states, emphasizing their commitment to enhancing consumer experiences.

Positive
  • Launch of Select Snooze Bites, which combines THC and CBN for effective nighttime use.
  • Expected fast-acting effects within 15-30 minutes due to nano-encapsulated THC.
  • Strong market demand, with CBN products generating $43 million in sales in key markets.
Negative
  • None.

Select's Snooze Bites are formulated with a 1:1 ratio of nano-emulsified THC oil and CBN for the perfect wind-down

WAKEFIELD, Mass., Oct. 13, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf'' or the "Company"), a leading international provider of consumer products in cannabis, has expanded its suite of innovative products with the addition of Select Snooze Bites, which are rolling out in several markets across the US this fall. Through the combined power of THC:CBN, this fast-acting platform is a true disruptor as an efficacious nighttime product.

Designed for the perfect wind-down, Snooze Bites combine a unique 1:1 ratio of fast-acting THC and long-lasting CBN. The scientifically developed formula incorporates 5mg of nano-encapsulated THC, which is made by creating tiny, water-soluble molecules from cannabis oil and is therefore quickly absorbed into the bloodstream with effects typically experienced within 15 to 30 minutes. When paired together with 5mg of CBN - a cannabinoid typically known for its relaxing and restorative qualities - users can expect a heightened combined experience.

According to BDS Analytics, the top reason adults choose to consume edibles is to "sleep better." Demand for CBN sleep products has surged in the country's top markets, reportedly generating $43 million in sales across California, Colorado, Nevada and Oregon in the first two quarters of 2021.

"Our R&D team is constantly working to elevate and customize the cannabis experience, and Select's latest product innovation reflects Curaleaf's ongoing commitment to our customers' unique lifestyles and preferences," said Joe Bayern, CEO of Curaleaf. "Our ultimate goal is to help consumers experience cannabis with confidence - and the launch of Select Snooze Bites is one more example of how we are striving to serve an even broader spectrum of customer needs."

Rich in terpenes such as myrcene, linalool, nerolidol and terpinolene, Select Snooze Bites will stand alongside the brand's Select Bites and Select Nano Bites which were relaunched earlier this year with a new look and better-than-ever taste. All Select Bites are made with a high stability, soft gelatin formula that provides a consistent experience with excellent texture and a delicious blackberry flavor.

Select Snooze Bites are currently available in Arizona and Nevada, and will soon launch in states such as California, Colorado, Maryland, and Maine. For more information on product availability, please visit https://selectcannabis.com/find-us.

About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 111 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 5,400 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com

FORWARD-LOOKING STATEMENTS
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the commercialization of Select Snooze Bites. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed April 28, 2021, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Carlos Madrazo, SVP Investor Relations
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
media@curaleaf.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleafs-select-brand-diversifies-edible-offerings-with-new-select-snooze-bites-301397918.html

SOURCE Curaleaf Holdings, Inc.

FAQ

What are Curaleaf's Select Snooze Bites?

Select Snooze Bites are a new product from Curaleaf that combines THC and CBN in a 1:1 ratio, designed for effective nighttime use.

When will Select Snooze Bites be available?

Select Snooze Bites are currently available in Arizona and Nevada, with plans to launch in California, Colorado, Maryland, and Maine soon.

How much THC and CBN is in Select Snooze Bites?

Each Select Snooze Bite contains 5mg of THC and 5mg of CBN.

What is the expected effect timeline for Select Snooze Bites?

Users can expect effects from Select Snooze Bites typically within 15 to 30 minutes after consumption.

What sales figures are associated with CBN products?

CBN sleep products have reportedly generated $43 million in sales across California, Colorado, Nevada, and Oregon during the first two quarters of 2021.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.30B
411.16M
29.87%
1.38%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York